Su Yun-Ai, Ye Chong, Xin Qin, Si Tianmei
Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Xi'an Janssen Pharmaceutical Ltd, Beijing, China.
Gen Psychiatr. 2024 Oct 8;37(5):e101649. doi: 10.1136/gpsych-2024-101649. eCollection 2024.
Major depressive disorder (MDD) with suicidal ideation or behaviour (MDSI) is associated with an increased risk of future suicide. The timely identification of suicide risk in patients with MDD and the subsequent implementation of interventions are crucially important to reduce their suffering and save lives. However, the early diagnosis of MDSI remains challenging across the world, as no objective diagnostic method is currently available. In China, the challenge is greater due to the social stigma associated with mental health problems, leading many patients to avoid reporting their suicidal ideation. Additionally, the neural mechanisms underlying MDSI are still unclear, which may hamper the development of effective interventions. We thus conducted this narrative review to summarise the existing neuroimaging studies of MDSI in Chinese patients, including those involving structural magnetic resonance imaging (MRI), functional MRI, neuronal electrophysiological source imaging of the brain dynamics with electroencephalography and magnetoencephalography. By synthesising the current research efforts in neuroimaging studies of Chinese patients with MDSI, we identified potential objective neuroimaging biomarkers, which may aid in the early identification of patients with MDSI who are at high suicide-related risk. Our findings also offer insights into the complex neural mechanisms underlying MDSI and suggest promising therapeutic targets. Furthermore, we propose future directions to discover novel imaging signatures, improve patient care, as well as help psychiatrists and clinical investigators plan their future research.
伴有自杀意念或行为的重度抑郁症(MDD)与未来自杀风险增加相关。及时识别MDD患者的自杀风险并随后实施干预措施对于减轻他们的痛苦和挽救生命至关重要。然而,由于目前尚无客观的诊断方法,MDSI的早期诊断在全球范围内仍然具有挑战性。在中国,由于与心理健康问题相关的社会耻辱感,这一挑战更大,导致许多患者避免报告他们的自杀意念。此外,MDSI潜在的神经机制仍不清楚,这可能会阻碍有效干预措施的发展。因此,我们进行了这项叙述性综述,以总结中国患者中MDSI的现有神经影像学研究,包括那些涉及结构磁共振成像(MRI)、功能MRI、利用脑电图和脑磁图对脑动力学进行神经元电生理源成像的研究。通过综合目前对中国MDSI患者神经影像学研究的成果,我们确定了潜在的客观神经影像学生物标志物,这可能有助于早期识别具有高自杀相关风险的MDSI患者。我们的研究结果还为MDSI潜在的复杂神经机制提供了见解,并提出了有前景的治疗靶点。此外,我们提出了未来的研究方向,以发现新的影像特征、改善患者护理,并帮助精神科医生和临床研究人员规划他们未来的研究。